Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-elemene Maintenance in Newly Diagnosed Malignant Glioma
NCT02629757Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2015
- Primary completion
- Apr 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Elemene in malignant glioma, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Elemene
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT02629757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629757.